All Community pharmacist articles – Page 6
-
NewsNovavax COVID-19 vaccine approved by the MHRA
The MHRA has given conditional marketing authorisation to Nuvaxovid, a COVID-19 vaccine developed by Novavax. It is the fifth COVID jab for which the MHRA has given regulatory approval
-
News
Firms fined £35 million for colluding over supply of prochlorperazine to the NHS
CMA issues £35 million fine over an illegal arrangement in the supply of prochlorperazine
-
News
NHS soups and shakes diet programme being expanded after successful pilot
The weight-loss programme, which began in 2020, has been successful in improving health outcomes of over 2000 individuals with type 2 diabetes
-
News
MHRA seeks views on making first vaginal HRT product available from pharmacies
The MHRA has launched a public consultation on a set of proposals to make Gina 10 microgram vaginal tablets (oestradiol) available from pharmacies without prescription
-
News
Lifestyle is likely to be more responsible for childhood obesity than mothers’ BMI
Researchers have found that higher maternal pre-/early-pregnancy BMI is not a key driver of higher adiposity in the next generation, suggesting that lifestyle is more likely to affect their child’s BMI than their own weight
-
Independent professional body guideline
PCDS atopic eczema guideline
An overview of the management of atopic eczema, covering taking a clinical history and step-wise management
-
NICE guideline
NICE CKS on infective conjunctivitis
A summary of guidance to assist community pharmacy teams with the diagnosis and management of infective conjunctivitis
-
News
Omicron subvariant BA.2: what we know so far
Although the BA.2 strain of Omicron may be even more transmissible than the original variant, current vaccines appear to offer the same level of protection against symptomatic disease
-
News
Current ‘safe’ alcohol consumption levels potentially harmful
New research suggests that even consuming less than the currently recommended safe level of alcohol is associated with increased cardiovascular risk, with researchers advising a reduction in safe level guidance
-
SIGN guideline
SIGN osteoporosis guideline
A brief summary of SIGN's guideline on management of osteoporosis and prevention of fragility fractures, including risk factors and a treatment algorithm.
-
News
Skin colour affects the accuracy of pulse oximetry readings for COVID-19
Concerns have been raised about the reliability of pulse oximetry for assessing the severity of COVID-19 infection in different ethnic groups, with researchers warning this may delay patients receiving appropriate care
-
News
Omicron survives longer on skin and surfaces than previous strains
A new pre-print study found that Omicron survived on skin for 21.1 hours and on plastic surfaces for 193.5 hours
-
News
SIGN publishes new guidance on eating disorders
The latest guideline from SIGN covers the management of people with eating disorders in any healthcare setting
-
News
Novel self-amplifying RNA COVID-19 vaccine scores well in safety but falls short in antibody response
The vaccine candidate has potential, but needs further modification to produce greater immune responses
-
News
Urolithin A may counteract age-associated muscle decline
A study found oral supplementation with urolithin A resulted in a significant improvement in muscle endurance
-
News
Analgesics are commonly prescribed for inflammatory arthritis despite little benefit
Patients with inflammatory arthritis continue to be routinely prescribed analgesics in primary care, despite limited evidence of their effectiveness
-
News
Community pharmacists pitch in to help tackle obesity
High street pharmacists have been enlisted to help fight the battle against rising numbers of people who are obese
-
News
An estimated 1.2 million deaths from antibiotic-resistant infections in 2019
The first global assessment of deaths from antibiotic-resistant infections has revealed the scale and impact of antimicrobial resistance across the world
-
News
Richard Meddings CBE appointed as the new Chair of NHS England
Mr Meddings will begin the 4-year role in March 2022, and will focus on the health service’s recovery from the pandemic and workforce expansion
-
News
Community pharmacy shouldering the burden of COVID testing oversight
Leyla Hannbeck urges the Government to engage more thoroughly with community pharmacy on public health strategy, to avoid future scenarios similar to the recent lateral flow device shortage
